ALS Sees New Treatment Option

A few years ago, the viral ice bucket challenge helped raised $115 million for sufferers of amyotrophic lateral sclerosis. Though the funds were used primarily for research, in twenty years, no medication has been approved until Radicava was funded.

Radicava is believed to protect against the worsening of ALS by working as an antioxidant. Antioxidants prevent a type of damage to the body known as oxidative damage.

Radicava is taken through an intravenous infusion (IV) and has to be given by a healthcare professional.

Like most experimental treatments, Radicava bears a number of side effects such as bruising, trouble walking, and the occasional allergic reaction. Medical professionals advise practicing alternative treatment options alongside Radicava. Because there are very few medicines available to those living with ALS, care is mostly limited to managing symptoms.

ALS is one of the most serious and devastating neurological disorders. One of the most challenging aspects of living with ALS is the fact that mental functioning is relatively preserved in most people with ALS as compared with physical decline. Knowing that there are few treatment options available is also frustrating.

Radicava was FDA-approved in the United States in May 2017.

Remember that being aware is not all about throwing a bucket of ice over your head. Do your research! Know how to act in emergencies.

--> Help make the world a better place by sharing this story with your friends: